2021
DOI: 10.9778/cmajo.20200231
|View full text |Cite
|
Sign up to set email alerts
|

Using the Edmonton Obesity Staging System in the real world: a feasibility study based on cross-sectional data

Abstract: Background: The Edmonton Obesity Staging System (EOSS) combined with body mass index (BMI) enables improved functional and prognostic assessment for patients. To facilitate application of the EOSS in practice, we aimed to create tools for capturing comorbidity assessments in electronic medical records and for automating the calculation of a patient’s EOSS stage. Methods: In this feasibility study, we used cross-sectional data to create a clinical dashboard to calculate … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 25 publications
0
13
0
Order By: Relevance
“…This means that even if you are in the Class III obesity range by BMI, it is possible to be at an EOSS Stage 0 or Stage 1 (subclinical risk factors). 33 This is important, as EOSS stage has been found to be far more predictive of survival rate, decreasing greatly with increasing stage number, compared to BMI. 35 The next 'A' is 'advise' .…”
Section: Symposium Reviewmentioning
confidence: 99%
See 1 more Smart Citation
“…This means that even if you are in the Class III obesity range by BMI, it is possible to be at an EOSS Stage 0 or Stage 1 (subclinical risk factors). 33 This is important, as EOSS stage has been found to be far more predictive of survival rate, decreasing greatly with increasing stage number, compared to BMI. 35 The next 'A' is 'advise' .…”
Section: Symposium Reviewmentioning
confidence: 99%
“…28 This is due to a person's BMI being a relatively poor predictor of survival, as evidenced by a study showing similar survival rates in people who are overweight (25.0-29.9 kg/m 2 ) or with Class III obesity (≥40 kg/ m 2 ). 33 The Edmonton Obesity Staging System (EOSS) 34 ranks people from Stage 0 (no clinical risk factors) to Stage 4 (end-stage disease), considering medical, physical, and psychological parameters, to describe comorbidities associated with excess weight. This means that even if you are in the Class III obesity range by BMI, it is possible to be at an EOSS Stage 0 or Stage 1 (subclinical risk factors).…”
Section: Symposium Reviewmentioning
confidence: 99%
“…It goes beyond BMI and considers factors such as obesity-related complications, functional limitations, and quality of life. The EOSS categorises individuals into four stages, offering a holistic approach to understanding obesity-related health (Table 2) (RCGP, 2023; Swaleh et al., 2021).…”
Section: Assessmentmentioning
confidence: 99%
“…The Asian obesity pandemic was initially marked by controversy over its definition. For obesity in the West, WHO guidelines indicate that body mass index (BMI; a ratio based on kg of mass per square meter of body surface) values of 25.0 kg/m 2 or higher are indicative of overweight status, while a BMI of 30.0 kg/m 2 or higher indicates Class I obesity (Table 1a) [22,23]. According to these guidelines, obesity prevalence in East Asia would only be around 2-4% compared to 10-20% in the West, but studies showing similar glucose intolerance in Asian women with BMIs of 23 kg/m 2 or higher and Western women with BMIs of 25 kg/m 2 or higher have led to International Obesity Task Force recommendations that the overweight and obese BMI cutoffs for Eastern Asians be revised to 23.0 kg/m 2 and 25.0 kg/m 2 , respectively (Table 1a) [24][25][26].…”
Section: Obesity and Metabolically Healthy Obesity Criteria: Impactmentioning
confidence: 99%